Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review

Arthritis Rheum. 2010 Jan;62(1):9-21. doi: 10.1002/art.25061.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Cyclophosphamide / adverse effects*
  • Cyclophosphamide / antagonists & inhibitors
  • Cystitis* / chemically induced
  • Cystitis* / epidemiology
  • Cystitis* / prevention & control
  • Databases, Bibliographic
  • Humans
  • Incidence
  • Mesna / pharmacology*
  • Protective Agents / pharmacology*
  • Rheumatic Diseases / drug therapy*
  • Urinary Bladder Neoplasms* / chemically induced
  • Urinary Bladder Neoplasms* / epidemiology
  • Urinary Bladder Neoplasms* / prevention & control

Substances

  • Antirheumatic Agents
  • Protective Agents
  • Cyclophosphamide
  • Mesna